Self-hypnosis in Patients Awaiting Lung Transplantation

Lung Transplantation Clinical Trial

— SelfHypTp  

Official title:

Interest of Learning Self-hypnosis in Patients Awaiting Lung Transplantation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02237976
• Other study ID #: 2014/47
• Secondary ID: 2014-A00538-39
• Status: Completed
• Phase: N/A
• Start date: July 31, 2014
• Est. completion date: July 31, 2018

Study information

• Verified date: March 2022
• Source: Hopital Foch
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The proposed study is designed to utilize a self-hypnosis training program for patients awaiting lung transplantation. This technique can increase their well being, particularly by decreasing postoperative pain.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 78
• Est. completion date: July 31, 2018
• Est. primary completion date: April 26, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 15 Years and older

Eligibility

Inclusion Criteria:

• patients aged 15 years or more requiring lung transplantation

Exclusion Criteria:

• patients who cannot participate in learning sessions of self-hypnosis for cultural , cognitive or environmental reasons

• patients who have participated in only one learning self-hypnosis session before transplantation

Related Conditions & MeSH terms

• Lung Transplantation

Intervention

Behavioral:
• Self-hypnosis

• Routine practice

Locations

Country	Name	City	State
France	Hôpital Foch	Suresnes	Hauts De Seine

Sponsors (1)

Lead Sponsor	Collaborator
Hopital Foch

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain after lung transplantation	Mean pain score in the 48 hours preceding the consultation performed one month after lung transplantation. Pain score is determined by the patient on a visual analogue scale (VAS) .	one month
Secondary	Pain before and after lung transplantation	Pain score is determined by the patient on a visual analogue scale (VAS) at the time of inscription on waiting list for transplantation, at the 8th day post transplantation, one and four months after transplantation	6 months
Secondary	Anxiety	Anxiety is determined by the patient on a visual analogue scale (VAS) at the time of inscription on waiting list for transplantation, at the 8th day post transplantation, one and four months after transplantation.; Anxiety is also determined by; the State Anxiety Inventory and the Trait Anxiety Inventory at the time of inscription on waiting list for transplantation,; the State Anxiety Inventory one and four months after transplantation.	6 months
Secondary	Coping	Coping is determined by the patient (Coping Strategies Questionnaire) at the time of inscription on waiting list for transplantation, and four months after transplantation	6 months
Secondary	Catastrophism	Catastrophism is determined by the patient (Sullivan questionnaire) at the time of inscription on waiting list for transplantation, and four months after transplantation	6 months
Secondary	Quality of life	Quality of life is determined by the patient (SF12 questionnaire) at the time of inscription on waiting list for transplantation, one and four months after transplantation	6 months
Secondary	Quality of life related to the procedure	Quality of life related to the procedure is determined by the patient using a specific questionnaire (Ringsted et al. Pain-related impairment of daily activities after thoracic surgery: a questionnaire validation. The Clinical Journal of Pain 2013;29(9):791-799) four months after transplantation	6 months
Secondary	Practice of self-hypnosis	Practice of self-hypnosis is determined by the patient using a specific questionnaire at the 8th day post transplantation, one and four months after transplantation.	6 months
Secondary	Forced expiratory volume in one second	Forced expiratory volume in one second is measured 4 months after transplantation.	6 months